 |
PDBsum entry 1ckb
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Complex (oncogene protein/peptide)
|
PDB id
|
|
|
|
1ckb
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Structure
3:215-226
(1995)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural basis for the specific interaction of lysine-containing proline-rich peptides with the N-terminal SH3 domain of c-Crk.
|
|
X.Wu,
B.Knudsen,
S.M.Feller,
J.Zheng,
A.Sali,
D.Cowburn,
H.Hanafusa,
J.Kuriyan.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
BACKGROUND: Proline-rich segments in the guanine nucleotide exchange factor C3G
bind much more strongly to the N-terminal Src homology 3 domain (SH3-N) of the
proto-oncogene product c-Crk than to other SH3 domains. The presence of a lysine
instead of an arginine in the peptides derived from C3G appears to be crucial
for this specificity towards c-Crk. RESULTS: In order to understand the chemical
basis of this specificity we have determined the crystal structure of Crk SH3-N
in complex with a high affinity peptide from C3G (PPPALPPKKR, Kd approximately 2
microM) at 1.5 A resolution. The peptide adopts a polyproline type II helix that
binds, as dictated by electrostatic complementarity, in reversed orientation
relative to the orientation seen in the earliest structures of SH3-peptide
complexes. A lysine in the C3G peptide is tightly coordinated by three acidic
residues in the SH3 domain. In contrast, the co-crystal structure of c-Crk SH3-N
and a peptide containing an arginine at the equivalent position (determined at
1.9 A resolution) reveals non-optimal geometry for the arginine and increased
disorder. CONCLUSIONS: The c-Crk SH3 domain engages in an unusual
lysine-specific interaction that is rarely seen in protein structures, and which
appears to be a key determinant of its unique ability to bind the C3G peptides
with high affinity.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 3.
Figure 3. Schematic diagram showing interactions between the
C3G peptide and the c-Crk SH3-N domain. The C3G peptide is
represented by the left-handed shaded ribbon, and peptide
residues that interact with the SH3 domain are indicated by
shaded circles. Residues in c-Crk SH3-N that interact with the
peptide are indicated by oval boxes (for hydrophobic residues)
and rectangular boxes (for acidic residues). Distances (in
å) between interacting residues are shown for the nearest
pair of carbon atoms (for hydrophobic interactions) and between
donor atom and acceptor atom for hydrogen bonds. Figure 3.
Schematic diagram showing interactions between the C3G peptide
and the c-Crk SH3-N domain. The C3G peptide is represented by
the left-handed shaded ribbon, and peptide residues that
interact with the SH3 domain are indicated by shaded circles.
Residues in c-Crk SH3-N that interact with the peptide are
indicated by oval boxes (for hydrophobic residues) and
rectangular boxes (for acidic residues). Distances (in å)
between interacting residues are shown for the nearest pair of
carbon atoms (for hydrophobic interactions) and between donor
atom and acceptor atom for hydrogen bonds.
|
 |
Figure 5.
Figure 5. Schematic diagram of the stereochemistry of the
lysine–carboxylate interaction at position P[−3] (after
lppolito et al. [26]). The amino group of the peptide lysine is
shown in a Newman projection, and the relative disposition of
the carboxylate groups and the hydrogen-bonding hydrogens in the
C3G/Crk complex are shown. Figure 5. Schematic diagram of
the stereochemistry of the lysine–carboxylate interaction at
position P[−3] (after lppolito et al. [[3]26]). The amino
group of the peptide lysine is shown in a Newman projection, and
the relative disposition of the carboxylate groups and the
hydrogen-bonding hydrogens in the C3G/Crk complex are shown.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Cell Press:
Structure
(1995,
3,
215-226)
copyright 1995.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
J.H.Cho,
V.Muralidharan,
M.Vila-Perello,
D.P.Raleigh,
T.W.Muir,
and
A.G.Palmer
(2011).
Tuning protein autoinhibition by domain destabilization.
|
| |
Nat Struct Mol Biol,
18,
550-555.
|
 |
|
|
|
|
 |
P.Sarkar,
T.Saleh,
S.R.Tzeng,
R.B.Birge,
and
C.G.Kalodimos
(2011).
Structural basis for regulation of the Crk signaling protein by a proline switch.
|
| |
Nat Chem Biol,
7,
51-57.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
S.Hoffmann,
S.A.Funke,
K.Wiesehan,
S.Moedder,
J.M.Glück,
S.Feuerstein,
M.Gerdts,
J.Mötter,
and
D.Willbold
(2010).
Competitively selected protein ligands pay their increase in specificity by a decrease in affinity.
|
| |
Mol Biosyst,
6,
116-123.
|
 |
|
|
|
|
 |
D.Van Valen,
M.Haataja,
and
R.Phillips
(2009).
Biochemistry on a leash: the roles of tether length and geometry in signal integration proteins.
|
| |
Biophys J,
96,
1275-1292.
|
 |
|
|
|
|
 |
R.B.Birge,
C.Kalodimos,
F.Inagaki,
and
S.Tanaka
(2009).
Crk and CrkL adaptor proteins: networks for physiological and pathological signaling.
|
| |
Cell Commun Signal,
7,
13.
|
 |
|
|
|
|
 |
P.Taylor,
E.Blackburn,
Y.G.Sheng,
S.Harding,
K.Y.Hsin,
D.Kan,
S.Shave,
and
M.D.Walkinshaw
(2008).
Ligand discovery and virtual screening using the program LIDAEUS.
|
| |
Br J Pharmacol,
153,
S55-S67.
|
 |
|
|
|
|
 |
R.A.Robinson,
X.Lu,
E.Y.Jones,
and
C.Siebold
(2008).
Biochemical and structural studies of ASPP proteins reveal differential binding to p53, p63, and p73.
|
| |
Structure,
16,
259-268.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
X.Huang,
D.Wu,
H.Jin,
D.Stupack,
and
J.Y.Wang
(2008).
Induction of cell retraction by the combined actions of Abl-CrkII and Rho-ROCK1 signaling.
|
| |
J Cell Biol,
183,
711-723.
|
 |
|
|
|
|
 |
B.Bommarius,
D.Maxwell,
A.Swimm,
S.Leung,
A.Corbett,
W.Bornmann,
and
D.Kalman
(2007).
Enteropathogenic Escherichia coli Tir is an SH2/3 ligand that recruits and activates tyrosine kinases required for pedestal formation.
|
| |
Mol Microbiol,
63,
1748-1768.
|
 |
|
|
|
|
 |
D.Adolph,
N.Flach,
K.Mueller,
D.H.Ostareck,
and
A.Ostareck-Lederer
(2007).
Deciphering the cross talk between hnRNP K and c-Src: the c-Src activation domain in hnRNP K is distinct from a second interaction site.
|
| |
Mol Cell Biol,
27,
1758-1770.
|
 |
|
|
|
|
 |
N.K.Banavali,
and
B.Roux
(2007).
Anatomy of a structural pathway for activation of the catalytic domain of Src kinase Hck.
|
| |
Proteins,
67,
1096-1112.
|
 |
|
|
|
|
 |
P.Sarkar,
C.Reichman,
T.Saleh,
R.B.Birge,
and
C.G.Kalodimos
(2007).
Proline cis-trans isomerization controls autoinhibition of a signaling protein.
|
| |
Mol Cell,
25,
413-426.
|
 |
|
|
|
|
 |
S.D.Stamenova,
M.E.French,
Y.He,
S.A.Francis,
Z.B.Kramer,
and
L.Hicke
(2007).
Ubiquitin binds to and regulates a subset of SH3 domains.
|
| |
Mol Cell,
25,
273-284.
|
 |
|
|
|
|
 |
S.J.Wrenn,
R.M.Weisinger,
D.R.Halpin,
and
P.B.Harbury
(2007).
Synthetic ligands discovered by in vitro selection.
|
| |
J Am Chem Soc,
129,
13137-13143.
|
 |
|
|
|
|
 |
V.De Filippis,
A.Draghi,
R.Frasson,
C.Grandi,
V.Musi,
A.Fontana,
and
A.Pastore
(2007).
o-Nitrotyrosine and p-iodophenylalanine as spectroscopic probes for structural characterization of SH3 complexes.
|
| |
Protein Sci,
16,
1257-1265.
|
 |
|
|
|
|
 |
Y.Kobashigawa,
M.Sakai,
M.Naito,
M.Yokochi,
H.Kumeta,
Y.Makino,
K.Ogura,
S.Tanaka,
and
F.Inagaki
(2007).
Structural basis for the transforming activity of human cancer-related signaling adaptor protein CRK.
|
| |
Nat Struct Mol Biol,
14,
503-510.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.Z.Lu,
T.Fujiwara,
H.Komatsuzawa,
M.Sugai,
and
J.Sakon
(2006).
Cell wall-targeting domain of glycylglycine endopeptidase distinguishes among peptidoglycan cross-bridges.
|
| |
J Biol Chem,
281,
549-558.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.R.Schiller,
K.Chakrabarti,
G.F.King,
N.I.Schiller,
B.A.Eipper,
and
M.W.Maciejewski
(2006).
Regulation of RhoGEF activity by intramolecular and intermolecular SH3 domain interactions.
|
| |
J Biol Chem,
281,
18774-18786.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
T.Hou,
K.Chen,
W.A.McLaughlin,
B.Lu,
and
W.Wang
(2006).
Computational analysis and prediction of the binding motif and protein interacting partners of the Abl SH3 domain.
|
| |
PLoS Comput Biol,
2,
e1.
|
 |
|
|
|
|
 |
X.Li,
Y.Chen,
Y.Liu,
J.Gao,
F.Gao,
M.Bartlam,
J.Y.Wu,
and
Z.Rao
(2006).
Structural basis of Robo proline-rich motif recognition by the srGAP1 Src homology 3 domain in the Slit-Robo signaling pathway.
|
| |
J Biol Chem,
281,
28430-28437.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.le Maire,
T.Weber,
S.Saunier,
I.Broutin,
C.Antignac,
A.Ducruix,
and
F.Dardel
(2005).
Solution NMR structure of the SH3 domain of human nephrocystin and analysis of a mutation-causing juvenile nephronophthisis.
|
| |
Proteins,
59,
347-355.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.Massenet,
S.Chenavas,
C.Cohen-Addad,
M.C.Dagher,
G.Brandolin,
E.Pebay-Peyroula,
and
F.Fieschi
(2005).
Effects of p47phox C terminus phosphorylations on binding interactions with p40phox and p67phox. Structural and functional comparison of p40phox and p67phox SH3 domains.
|
| |
J Biol Chem,
280,
13752-13761.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
C.Reichman,
K.Singh,
Y.Liu,
S.Singh,
H.Li,
J.E.Fajardo,
A.Fiser,
and
R.B.Birge
(2005).
Transactivation of Abl by the Crk II adapter protein requires a PNAY sequence in the Crk C-terminal SH3 domain.
|
| |
Oncogene,
24,
8187-8199.
|
 |
|
|
|
|
 |
G.U.Gangenahalli,
V.K.Singh,
Y.K.Verma,
P.Gupta,
R.K.Sharma,
R.Chandra,
S.Gulati,
and
P.M.Luthra
(2005).
Three-dimensional structure prediction of the interaction of CD34 with the SH3 domain of Crk-L.
|
| |
Stem Cells Dev,
14,
470-477.
|
 |
|
|
|
|
 |
L.J.Ball,
R.Kühne,
J.Schneider-Mergener,
and
H.Oschkinat
(2005).
Recognition of Proline-Rich Motifs by Protein-Protein-Interaction Domains.
|
| |
Angew Chem Int Ed Engl,
44,
2852-2869.
|
 |
|
|
|
|
 |
Q.Deng,
J.Sun,
and
J.T.Barbieri
(2005).
Uncoupling Crk signal transduction by Pseudomonas exoenzyme T.
|
| |
J Biol Chem,
280,
35953-35960.
|
 |
|
|
|
|
 |
J.A.Marles,
S.Dahesh,
J.Haynes,
B.J.Andrews,
and
A.R.Davidson
(2004).
Protein-protein interaction affinity plays a crucial role in controlling the Sho1p-mediated signal transduction pathway in yeast.
|
| |
Mol Cell,
14,
813-823.
|
 |
|
|
|
|
 |
S.Donnini,
and
A.H.Juffer
(2004).
Calculation of affinities of peptides for proteins.
|
| |
J Comput Chem,
25,
393-411.
|
 |
|
|
|
|
 |
Y.Opatowsky,
C.C.Chen,
K.P.Campbell,
and
J.A.Hirsch
(2004).
Structural analysis of the voltage-dependent calcium channel beta subunit functional core and its complex with the alpha 1 interaction domain.
|
| |
Neuron,
42,
387-399.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.Harkiolaki,
M.Lewitzky,
R.J.Gilbert,
E.Y.Jones,
R.P.Bourette,
G.Mouchiroud,
H.Sondermann,
I.Moarefi,
and
S.M.Feller
(2003).
Structural basis for SH3 domain-mediated high-affinity binding between Mona/Gads and SLP-76.
|
| |
EMBO J,
22,
2571-2582.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
P.B.van Hennik,
J.P.ten Klooster,
J.R.Halstead,
C.Voermans,
E.C.Anthony,
N.Divecha,
and
P.L.Hordijk
(2003).
The C-terminal domain of Rac1 contains two motifs that control targeting and signaling specificity.
|
| |
J Biol Chem,
278,
39166-39175.
|
 |
|
|
|
|
 |
T.Kaneko,
T.Kumasaka,
T.Ganbe,
T.Sato,
K.Miyazawa,
N.Kitamura,
and
N.Tanaka
(2003).
Structural insight into modest binding of a non-PXXP ligand to the signal transducing adaptor molecule-2 Src homology 3 domain.
|
| |
J Biol Chem,
278,
48162-48168.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
B.Fazi,
M.J.Cope,
A.Douangamath,
S.Ferracuti,
K.Schirwitz,
A.Zucconi,
D.G.Drubin,
M.Wilmanns,
G.Cesareni,
and
L.Castagnoli
(2002).
Unusual binding properties of the SH3 domain of the yeast actin-binding protein Abp1: structural and functional analysis.
|
| |
J Biol Chem,
277,
5290-5298.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
H.Delbrück,
G.Ziegelin,
E.Lanka,
and
U.Heinemann
(2002).
An Src homology 3-like domain is responsible for dimerization of the repressor protein KorB encoded by the promiscuous IncP plasmid RP4.
|
| |
J Biol Chem,
277,
4191-4198.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.J.Kogan,
I.Dalcol,
P.Gorostiza,
C.Lopez-Iglesias,
R.Pons,
M.Pons,
F.Sanz,
and
E.Giralt
(2002).
Supramolecular properties of the proline-rich gamma-Zein N-terminal domain.
|
| |
Biophys J,
83,
1194-1204.
|
 |
|
|
|
|
 |
G.Tuchscherer,
D.Grell,
Y.Tatsu,
P.Durieux,
J.Fernandez-Carneado,
B.Hengst,
C.Kardinal,
and
S.Feller
(2001).
Targeting Molecular Recognition: Exploring the Dual Role of Functional Pseudoprolines in the Design of SH3 Ligands This work was supported by the Swiss National Science Foundation.
|
| |
Angew Chem Int Ed Engl,
40,
2844-2848.
|
 |
|
|
|
|
 |
K.V.Kishan,
M.E.Newcomer,
T.H.Rhodes,
and
S.D.Guilliot
(2001).
Effect of pH and salt bridges on structural assembly: molecular structures of the monomer and intertwined dimer of the Eps8 SH3 domain.
|
| |
Protein Sci,
10,
1046-1055.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.Han,
V.V.Gurevich,
S.A.Vishnivetskiy,
P.B.Sigler,
and
C.Schubert
(2001).
Crystal structure of beta-arrestin at 1.9 A: possible mechanism of receptor binding and membrane Translocation.
|
| |
Structure,
9,
869-880.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
P.Barnett,
G.Bottger,
A.T.Klein,
H.F.Tabak,
and
B.Distel
(2000).
The peroxisomal membrane protein Pex13p shows a novel mode of SH3 interaction.
|
| |
EMBO J,
19,
6382-6391.
|
 |
|
|
|
|
 |
A.Blaukat,
I.Ivankovic-Dikic,
E.Grönroos,
F.Dolfi,
G.Tokiwa,
K.Vuori,
and
I.Dikic
(1999).
Adaptor proteins Grb2 and Crk couple Pyk2 with activation of specific mitogen-activated protein kinase cascades.
|
| |
J Biol Chem,
274,
14893-14901.
|
 |
|
|
|
|
 |
A.M.Mongioví,
P.R.Romano,
S.Panni,
M.Mendoza,
W.T.Wong,
A.Musacchio,
G.Cesareni,
and
P.P.Di Fiore
(1999).
A novel peptide-SH3 interaction.
|
| |
EMBO J,
18,
5300-5309.
|
 |
|
|
|
|
 |
A.Nakagawa,
T.Nakashima,
M.Taniguchi,
H.Hosaka,
M.Kimura,
and
I.Tanaka
(1999).
The three-dimensional structure of the RNA-binding domain of ribosomal protein L2; a protein at the peptidyl transferase center of the ribosome.
|
| |
EMBO J,
18,
1459-1467.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
B.Aghazadeh,
and
M.K.Rosen
(1999).
Ligand recognition by SH3 and WW domains: the role of N-alkylation in PPII helices.
|
| |
Chem Biol,
6,
R241-R246.
|
 |
|
|
|
|
 |
C.Kardinal,
G.Posern,
J.Zheng,
B.S.Knudsen,
I.Moarefi,
and
S.M.Feller
(1999).
Rational development of cell-penetrating high affinity SH3 domain binding peptides that selectively disrupt the signal transduction of Crk family adapters. Amgen Peptide Technology Group.
|
| |
Ann N Y Acad Sci,
886,
289-292.
|
 |
|
|
|
|
 |
W.L.Lee,
E.M.Ostap,
H.G.Zot,
and
T.D.Pollard
(1999).
Organization and ligand binding properties of the tail of Acanthamoeba myosin-IA. Identification of an actin-binding site in the basic (tail homology-1) domain.
|
| |
J Biol Chem,
274,
35159-35171.
|
 |
|
|
|
|
 |
Z.Gu,
D.G.Drueckhammer,
L.Kurz,
K.Liu,
D.P.Martin,
and
A.McDermott
(1999).
Solid state NMR studies of hydrogen bonding in a citrate synthase inhibitor complex.
|
| |
Biochemistry,
38,
8022-8031.
|
 |
|
|
|
|
 |
D.J.Owen,
P.Wigge,
Y.Vallis,
J.D.Moore,
P.R.Evans,
and
H.T.McMahon
(1998).
Crystal structure of the amphiphysin-2 SH3 domain and its role in the prevention of dynamin ring formation.
|
| |
EMBO J,
17,
5273-5285.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.J.Mathiesen,
A.Holm,
M.Christiansen,
J.Blom,
K.Hansen,
S.Ostergaard,
and
M.Theisen
(1998).
The dominant epitope of Borrelia garinii outer surface protein C recognized by sera from patients with neuroborreliosis has a surface-exposed conserved structural motif.
|
| |
Infect Immun,
66,
4073-4079.
|
 |
|
|
|
|
 |
S.Knapp,
P.T.Mattson,
P.Christova,
K.D.Berndt,
A.Karshikoff,
M.Vihinen,
C.I.Smith,
and
R.Ladenstein
(1998).
Thermal unfolding of small proteins with SH3 domain folding pattern.
|
| |
Proteins,
31,
309-319.
|
 |
|
|
|
|
 |
D.C.Dalgarno,
M.C.Botfield,
and
R.J.Rickles
(1997).
SH3 domains and drug design: ligands, structure, and biological function.
|
| |
Biopolymers,
43,
383-400.
|
 |
|
|
|
|
 |
H.V.Patel,
S.R.Tzeng,
C.Y.Liao,
S.H.Chen,
and
J.W.Cheng
(1997).
SH3 domain of Bruton's tyrosine kinase can bind to proline-rich peptides of TH domain of the kinase and p120cbl.
|
| |
Proteins,
29,
545-552.
|
 |
|
|
|
|
 |
J.Kuriyan,
and
D.Cowburn
(1997).
Modular peptide recognition domains in eukaryotic signaling.
|
| |
Annu Rev Biophys Biomol Struct,
26,
259-288.
|
 |
|
|
|
|
 |
K.S.Thorn,
H.E.Christensen,
R.Shigeta,
D.Huddler,
L.Shalaby,
U.Lindberg,
N.H.Chua,
and
C.E.Schutt
(1997).
The crystal structure of a major allergen from plants.
|
| |
Structure,
5,
19-32.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
K.V.Kishan,
G.Scita,
W.T.Wong,
P.P.Di Fiore,
and
M.E.Newcomer
(1997).
The SH3 domain of Eps8 exists as a novel intertwined dimer.
|
| |
Nat Struct Biol,
4,
739-743.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.Anafi,
F.Kiefer,
G.D.Gish,
G.Mbamalu,
N.N.Iscove,
and
T.Pawson
(1997).
SH2/SH3 adaptor proteins can link tyrosine kinases to a Ste20-related protein kinase, HPK1.
|
| |
J Biol Chem,
272,
27804-27811.
|
 |
|
|
|
|
 |
N.M.Mahoney,
P.A.Janmey,
and
S.C.Almo
(1997).
Structure of the profilin-poly-L-proline complex involved in morphogenesis and cytoskeletal regulation.
|
| |
Nat Struct Biol,
4,
953-960.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.Arold,
P.Franken,
M.P.Strub,
F.Hoh,
S.Benichou,
R.Benarous,
and
C.Dumas
(1997).
The crystal structure of HIV-1 Nef protein bound to the Fyn kinase SH3 domain suggests a role for this complex in altered T cell receptor signaling.
|
| |
Structure,
5,
1361-1372.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
D.A.Renzoni,
D.J.Pugh,
G.Siligardi,
P.Das,
C.J.Morton,
C.Rossi,
M.D.Waterfield,
I.D.Campbell,
and
J.E.Ladbury
(1996).
Structural and thermodynamic characterization of the interaction of the SH3 domain from Fyn with the proline-rich binding site on the p85 subunit of PI3-kinase.
|
| |
Biochemistry,
35,
15646-15653.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.Bliska
(1996).
How pathogens exploit interactions mediated by SH3 domains.
|
| |
Chem Biol,
3,
7.
|
 |
|
|
|
|
 |
J.Qin,
G.M.Clore,
W.P.Kennedy,
J.Kuszewski,
and
A.M.Gronenborn
(1996).
The solution structure of human thioredoxin complexed with its target from Ref-1 reveals peptide chain reversal.
|
| |
Structure,
4,
613-620.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.Matsuda,
S.Ota,
R.Tanimura,
H.Nakamura,
K.Matuoka,
T.Takenawa,
K.Nagashima,
and
T.Kurata
(1996).
Interaction between the amino-terminal SH3 domain of CRK and its natural target proteins.
|
| |
J Biol Chem,
271,
14468-14472.
|
 |
|
|
|
|
 |
M.Matsuda,
and
T.Kurata
(1996).
Emerging components of the Crk oncogene product: the first identified adaptor protein.
|
| |
Cell Signal,
8,
335-340.
|
 |
|
|
|
|
 |
M.T.Pisabarro,
and
L.Serrano
(1996).
Rational design of specific high-affinity peptide ligands for the Abl-SH3 domain.
|
| |
Biochemistry,
35,
10634-10640.
|
 |
|
|
|
|
 |
S.Grzesiek,
A.Bax,
G.M.Clore,
A.M.Gronenborn,
J.S.Hu,
J.Kaufman,
I.Palmer,
S.J.Stahl,
and
P.T.Wingfield
(1996).
The solution structure of HIV-1 Nef reveals an unexpected fold and permits delineation of the binding surface for the SH3 domain of Hck tyrosine protein kinase.
|
| |
Nat Struct Biol,
3,
340-345.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
T.W.Muir,
P.E.Dawson,
M.C.Fitzgerald,
and
S.B.Kent
(1996).
Probing the chemical basis of binding activity in an SH3 domain by protein signature analysis.
|
| |
Chem Biol,
3,
817-825.
|
 |
|
|
|
|
 |
W.A.Lim
(1996).
Reading between the lines: SH3 recognition of an intact protein.
|
| |
Structure,
4,
657-659.
|
 |
|
|
|
|
 |
B.J.Mayer,
and
M.J.Eck
(1995).
SH3 domains. Minding your p's and q's.
|
| |
Curr Biol,
5,
364-367.
|
 |
|
|
|
|
 |
C.H.Lee,
B.Leung,
M.A.Lemmon,
J.Zheng,
D.Cowburn,
J.Kuriyan,
and
K.Saksela
(1995).
A single amino acid in the SH3 domain of Hck determines its high affinity and specificity in binding to HIV-1 Nef protein.
|
| |
EMBO J,
14,
5006-5015.
|
 |
|
|
|
|
 |
H.I.Chen,
and
M.Sudol
(1995).
The WW domain of Yes-associated protein binds a proline-rich ligand that differs from the consensus established for Src homology 3-binding modules.
|
| |
Proc Natl Acad Sci U S A,
92,
7819-7823.
|
 |
|
|
|
|
 |
M.Tanaka,
R.Gupta,
and
B.J.Mayer
(1995).
Differential inhibition of signaling pathways by dominant-negative SH2/SH3 adapter proteins.
|
| |
Mol Cell Biol,
15,
6829-6837.
|
 |
|
|
|
|
 |
S.Feng,
C.Kasahara,
R.J.Rickles,
and
S.L.Schreiber
(1995).
Specific interactions outside the proline-rich core of two classes of Src homology 3 ligands.
|
| |
Proc Natl Acad Sci U S A,
92,
12408-12415.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
Y.Q.Gosser,
J.Zheng,
M.Overduin,
B.J.Mayer,
and
D.Cowburn
(1995).
The solution structure of Abl SH3, and its relationship to SH2 in the SH(32) construct.
|
| |
Structure,
3,
1075-1086.
|
 |
|
PDB code:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |